Few and far between: how HIV may be evading antibody avidity.

Código QR

Few and far between: how HIV may be evading antibody avidity.

Guardado en:

Detalles Bibliográficos
Autores principales:	Joshua S Klein, Pamela J Bjorkman
Formato:	article
Lenguaje:	EN
Publicado:	Public Library of Science (PLoS) 2010
Materias:	Immunologic diseases. Allergy RC581-607 Biology (General) QH301-705.5
Acceso en línea:	https://doaj.org/article/a8e1c8b97beb436cbe8d1eaa395dc4f3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

AVIDITY EVALUATION OF LOCAL IgA ANTIBODIES IN PERSONS IMMUNIZED WITH LIVE INFLUENZA VACCINE
por: S. A. Donina, et al.
Publicado: (2014)

Effects of inoculation route and dose on production and avidity of IgY antibodies
por: Michele Pagliari Oliveira Montini, et al.
Publicado: (2018)

Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants
por: Sonia Budroni, et al.
Publicado: (2021)

Juxtamembrane shedding of Plasmodium falciparum AMA1 is sequence independent and essential, and helps evade invasion-inhibitory antibodies.
por: Anna Olivieri, et al.
Publicado: (2011)

Rapid perturbation in viremia levels drives increases in functional avidity of HIV-specific CD8 T cells.
por: Selena Viganò, et al.
Publicado: (2013)

HIV controller CD4+ T cells respond to minimal amounts of Gag antigen due to high TCR avidity.
por: Benoît Vingert, et al.
Publicado: (2010)

Subclass and avidity of circumsporozoite protein specific antibodies associate with protection status against malaria infection
por: Kelly E. Seaton, et al.
Publicado: (2021)

Seroprevalence of Toxoplasma gondii IgG antibody in HIV-infected patients at the Lagos University Teaching Hospital
por: Osunkalu VO, et al.
Publicado: (2011)

Antibodies
Publicado: (2012)

An update on the use of Atripla&reg; in the treatment of HIV in the United States
por: Michael A Horberg, et al.
Publicado: (2010)

Salmonella Typhimurium impairs glycolysis-mediated acidification of phagosomes to evade macrophage defense.
por: Saray Gutiérrez, et al.
Publicado: (2021)

Vibrio cholerae evades neutrophil extracellular traps by the activity of two extracellular nucleases.
por: Andrea Seper, et al.
Publicado: (2013)

Impact of comorbidities and drug therapy on development of renal impairment in a predominantly African American and Hispanic HIV clinic population
por: M Keith Rawlings, et al.
Publicado: (2011)

DC8 and DC13 var genes associated with severe malaria bind avidly to diverse endothelial cells.
por: Marion Avril, et al.
Publicado: (2013)

Assessing the HIV rapid test in the fight against the HIV/AIDS epidemic in Trinidad
por: Mungrue K, et al.
Publicado: (2013)

The association of anti-CD74 antibody with spondyloarthropathies
por: Seda Çolak, et al.
Publicado: (2021)

HIV reservoirs in vivo and new strategies for possible eradication of HIV from the reservoir sites
por: Nitin K Saksena, et al.
Publicado: (2010)

Relationship between socioeconomic status and HIV infection in a rural tertiary health center
por: Ogunmola OJ, et al.
Publicado: (2014)

TLRs in COVID-19: How they drive immunopathology and the rationale for modulation
por: F. Linzee Mabrey, et al.
Publicado: (2021)

Role of darunavir in the management of HIV infection
por: R Monica Lascar, et al.
Publicado: (2009)

The use of preexposure treatments for HIV prophylaxis
por: Majid A, et al.
Publicado: (2012)

Arguments for and against HIV self-testing
por: Wood BR, et al.
Publicado: (2014)

HIV-related neuropathy: current perspectives
por: Sch&uuml;tz SG, et al.
Publicado: (2013)

Perceptions and activities of religious leaders on the prevention of HIV/AIDS and care of people living with the HIV infection in Ibadan, Nigeria
por: Asekun-Olarinmoye IO, et al.
Publicado: (2013)

The association between adolescent entry into the trucking industry and risk of HIV among long-distance truck drivers in India
por: Mishra RM, et al.
Publicado: (2012)

Role of raltegravir in the management of HIV-1 infection
por: Okeke NL, et al.
Publicado: (2011)

Current perspectives in HIV post-exposure prophylaxis
por: Sultan B, et al.
Publicado: (2014)

The geography of HIV/AIDS prevalence rates in Botswana
por: Kandala NB, et al.
Publicado: (2012)

Lipodystrophy in HIV patients: its challenges and management approaches
por: Singhania R, et al.
Publicado: (2011)

Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS
por: Pandey KK
Publicado: (2014)

STD patients’ preferences for HIV prevention strategies
por: Castro JG, et al.
Publicado: (2014)

Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy
por: Bedimo R
Publicado: (2011)

Profile of darunavir in the management of treatment-experienced HIV patients
por: Cameron Wolfe, et al.
Publicado: (2009)

Immune reconstitution inflammatory syndrome in HIV-infected patients
por: Walker NF, et al.
Publicado: (2015)

Osteopenia and osteoporosis in people living with HIV: multiprofessional approach
por: Lima AL, et al.
Publicado: (2011)

The effect of aging, nutrition, and exercise during HIV infection
por: Gabriel Somarriba, et al.
Publicado: (2010)

Managing dyslipidemia in HIV/AIDS patients: challenges and solutions
por: Husain NE, et al.
Publicado: (2014)

Safety of protease inhibitors in HIV-infected pregnant women
por: Chougrani I, et al.
Publicado: (2013)

The plant pathogen Pseudomonas syringae pv. tomato is genetically monomorphic and under strong selection to evade tomato immunity.
por: Rongman Cai, et al.
Publicado: (2011)

Increased mortality among HIV-positive men on antiretroviral therapy: survival differences between sexes explained by late initiation in Uganda
por: Kanters S, et al.
Publicado: (2013)